Discovery of Ledipasvir (GS-5885): A Potent, Once-Daily Oral NS5A Inhibitor for the Treatment of Hepatitis C Virus Infection von Link, John O., Taylor, James G., Xu, Lianhong, Mitchell, Michael, Guo, Hongyan, Liu, Hongtao, Kato, Darryl, Kirschberg, Thorsten, Sun, Jianyu, Squires, Neil, Parrish, Jay, Keller, Terry, Yang, Zheng-Yu, Yang, Chris, Matles, Mike, Wang, Yujin, Wang, Kelly, Cheng, Guofeng, Tian, Yang, Mogalian, Erik, Mondou, Elsa, Cornpropst, Melanie, Perry, Jason, Desai, Manoj C.

Volltext

A Metabolic Labeling Approach toward Proteomic Analysis of Mucin-Type O-Linked Glycosylation von Hang, Howard C., Yu, Chong, Kato, Darryl L., Bertozzi, Carolyn R.

Volltext

Discovery of the pan-genotypic hepatitis C virus NS3/4A protease inhibitor voxilaprevir (GS-9857): A component of Vosevi von Taylor, James G., Zipfel, Sheila, Ramey, Kyla, Vivian, Randy, Schrier, Adam, Karki, Kapil K., Katana, Ashley, Kato, Darryl, Kobayashi, Tetsuya, Martinez, Ruben, Sangi, Michael, Siegel, Dustin, Tran, Chinh V., Yang, Zheng-Yu, Zablocki, Jeff, Yang, Cheng Y., Wang, Yujin, Wang, Kelly, Chan, Katie, Barauskas, Ona, Cheng, Guofeng, Jin, Debi, Schultz, Brian E., Appleby, Todd, Villaseñor, Armando G., Link, John O.

Volltext

Enantioselective Synthesis of (+)-Cephalostatin 1 von Fortner, Kevin C, Kato, Darryl, Tanaka, Yoshiki, Shair, Matthew D

Volltext

Discovery of velpatasvir (GS-5816): A potent pan-genotypic HCV NS5A inhibitor in the single-tablet regimens Vosevi® and Epclusa von Link, John O., Taylor, James G., Trejo-Martin, Alejandra, Kato, Darryl, Katana, Ashley A., Krygowski, Evan S., Yang, Zheng-Yu, Zipfel, Sheila, Cottell, Jeromy J., Bacon, Elizabeth M., Tran, Chinh V., Yang, Cheng Y., Wang, Yujin, Wang, Kelly W., Zhao, Guangyu, Cheng, Guofeng, Tian, Yang, Gong, Ruoyu, Lee, Yu-Jen, Yu, Mei, Gorman, Eric, Mogalian, Erik, Perry, Jason K.

Volltext

Direct binding of ledipasvir to HCV NS5A: mechanism of resistance to an HCV antiviral agent von Kwon, Hyock Joo, Xing, Weimei, Chan, Katie, Niedziela-Majka, Anita, Brendza, Katherine M, Kirschberg, Thorsten, Kato, Darryl, Link, John O, Cheng, Guofeng, Liu, Xiaohong, Sakowicz, Roman

Volltext

Correction to Discovery of Ledipasvir (GS-5885): A Potent, Once-Daily Oral NS5A Inhibitor for the Treatment of Hepatitis C Virus Infection von Link, John O, Taylor, James G, Xu, Lianhong, Mitchell, Michael, Guo, Hongyan, Liu, Hongtao, Kato, Darryl, Kirschberg, Thorsten, Sun, Jianyu, Squires, Neil, Parrish, Jay, Kellar, Terry, Yang, Zheng-Yu, Yang, Chris, Matles, Mike, Wang, Yujin, Wang, Kelly, Cheng, Guofeng, Tian, Yang, Mogalian, Erik, Mondou, Elsa, Cornpropst, Melanie, Perry, Jason, Desai, Manoj C

Volltext

Long-acting capsid inhibitor protects macaques from repeat SHIV challenges von Vidal, Samuel J., Bekerman, Elena, Hansen, Derek, Lu, Bing, Wang, Kelly, Mwangi, Judy, Rowe, William, Campigotto, Federico, Zheng, Jim, Kato, Darryl, Chandrashekar, Abishek, Barrett, Julia, Patel, Shivani, Wan, Huahua, Anioke, Tochi, Mercado, Noe B., Nkolola, Joseph P., Ferguson, Melissa J., Rinaldi, William J., Callebaut, Christian, Blair, Wade, Cihlar, Tomas, Geleziunas, Romas, Yant, Stephen R., Barouch, Dan H.

Volltext

Neurotoxicity of an Hepatitis B Virus (HBV) Transcript Inhibitor in 13-Week Rat and Monkey Studies von Lake, April D, Holsapple, Kevin, McDonnell, Tanya, Arezzo, Joseph C, Ramirez, Ricardo, Gamelin, Lindsay, Yu, Mei, Glatt, Dylan, Dick, Ryan, Xie, Xiaodong, Choy, Regina, Cheng, Guofeng, Tay, Chin H, Chester, Anne, Kato, Darryl, Burns-Naas, Leigh Ann

Volltext

Discovery of Hepatitis B Virus Surface Antigen Suppressor GS-8873 von Kato, Darryl, Choy, Regina Wai-Yan, Canales, Eda, Dick, Ryan A., Lake, April D., Shapiro, Nathan D., Chin, Elbert, Li, Jiayao, Zhang, Jennifer R., Wu, Qiaoyin, Saito, Roland D., Metobo, Sammy, Aktoudianakis, Evangelos, Schroeder, Scott D., Yang, Zheng-Yu, Glatt, Dylan M., Balsitis, Scott, Gamelin, Lindsay, Yu, Mei, Cheng, Guofeng, Delaney, William E., Link, John O.

Volltext

Enantioselective Synthesis of (+)-Cephalostatin 1 von Fortner, Kevin, Kato, Darryl, Tanaka, Yoshiki, Shair, Matthew David

Volltext

QUINAZOLINYL-INDAZOLE DERIVATIVES AS THERAPEUTIC COMPOUNDS FOR HIV von FARAND, Julie, KATO, Darryl, MACK, James B.C

Volltext bestellen

Direct Binding of Ledipasvir to HCV NS5A: Mechanism of Resistance to an HCV Antiviral Agent: e0122844 von Kwon, Hyock Joo, Xing, Weimei, Chan, Katie, Niedziela-Majka, Anita, Brendza, Katherine M, Kirschberg, Thorsten, Kato, Darryl, Link, John O, Cheng, Guofeng, Liu, Xiaohong

Volltext

Capsid inhibitors for the treatment of HIV von LAZERWITH, Scott E, CHOU, Chienhung, SCHROEDER, Scott D, KATO, Darryl, LINK, John O, TSE, Winston C, ZHANG, Jennifer R

Volltext bestellen

Therapeutic compounds for HIV virus infection von Guney, Tezcan, Mack, James B. C, Kato, Darryl, Farand, Julie, Link, John O, Watkins, William J

Volltext bestellen

ANTI-HIV COMPOUNDS von LINK, JOHN O, CHIN, ELBERT, SHAPIRO, NATHAN, YANG, ZHENG-YU, KATO, DARRYL

Volltext bestellen

Capsid inhibitors for the treatment of HIV von LAZERWITH, Scott E, CHOU, Chienhung, SCHROEDER, Scott D, KATO, Darryl, LINK, John O, TSE, Winston C, ZHANG, Jennifer R

Volltext bestellen

Anti-HIV compounds von YANG, Zheng-Yu, KATO, Darryl, LINK, John O, CHIN, Elbert, SHAPIRO, Nathan

Volltext bestellen

CAPSID INHIBITORS FOR THE TREATMENT OF HIV von Schroeder, Scott D, Tse, Winston C, Lazerwith, Scott E, Kato, Darryl, Chou, Chienhung, Zhang, Jennifer R

Volltext bestellen

Capsid inhibitors for the treatment of HIV von LAZERWITH, Scott E, CHOU, Chienhung, SCHROEDER, Scott D, KATO, Darryl, TSE, Winston C, ZHANG, Jennifer R

Volltext bestellen